×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

9 Meters Biopharma Inc. (NMTR) NASDAQ

$0.07 - (-)

Market Cap: -

As of 07/25/23 12:00 AM EDT. Market closed.

(NMTR)

9 Meters Biopharma Inc. (NMTR)
NASDAQ

$0.07
- (-)

Market Cap: -

As of 07/25/23 12:00 AM EDT. Market closed.

Add to Portfolio

9 meters biopharma, inc., a clinical-stage biotechnology company, focuses on patients with rare disorders and unmet needs. the company's pipeline includes drug candidates for short bowel syndrome (sbs) and celiac disease. it is developing nm-002, a long-acting injectable glp-1 agonist that is in a phase 2 clinical trial for sbs; and larazotide, a phase 3-stage therapeutic in development for ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Computer Storage Device Manufacturing
CEO
Sandeep Laumas
Full Time Employees
18
URL
Address
8480 Honeycutt Rd Ste 120, North Carolina, Raleigh, 27615.
Sector
Manufacturing
Industry
Computer Storage Device Manufacturing
CEO
Sandeep Laumas
Full Time Employees
18
Address
8480 Honeycutt Rd Ste 120, North Carolina, Raleigh, 27615.
PRICE CHART FOR 9 METERS BIOPHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.11
Previous Close
$0.07
Days Range
$0.07 - $0.11
52 week range
- - -
Volume
9,957,840
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
14,459,690
Open
$0.11
Previous Close
$0.07
Days Range
$0.07 - $0.11
52 week range
- - -
Volume
9,957,840
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
14,459,690
FINANCIAL STATEMENTS FOR 9 METERS BIOPHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR 9 METERS BIOPHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Sensenig BethanyChief Financial OfficerApr 21, 2023 Sale$1.219,10011,01141,077Apr 21, 2023, 05:08 PM
Sirgo Mark ADirectorJul 01, 2022 Option Exercise$0.25175,00042,9621,560,428Jul 22, 2022, 04:21 PM
Temperato JohnChief Executive OfficerJul 06, 2022 Buy$0.23125,00028,4621,427,522Jul 08, 2022, 08:01 AM
Sirgo Mark ADirectorJul 01, 2022 Buy$0.25175,00042,9621,454,045Jul 06, 2022, 04:43 PM
Constantino Michael T.DirectorMay 23, 2022 Buy$0.4816,0007,60860,509May 24, 2022, 04:01 PM
Temperato JohnChief Executive OfficerMay 18, 2022 Buy$0.4550,00022,2851,302,522May 19, 2022, 04:09 PM
Sirgo Mark ADirectorMay 18, 2022 Buy$0.47106,38350,0001,385,428May 19, 2022, 04:01 PM
Constantino Michael T.DirectorAug 20, 2020 Buy$0.7526,50920,00126,509Mar 21, 2022, 04:17 PM
Sirgo Mark ADirectorMar 03, 2022 Buy$0.5886,45050,0031,279,045Mar 07, 2022, 08:01 AM
Temperato JohnChief Executive OfficerMar 03, 2022 Buy$0.56100,00055,5901,252,522Mar 04, 2022, 08:00 AM
Sirgo Mark ADirectorDec 02, 2021 Buy$0.8950,00044,5001,242,595Dec 03, 2021, 07:34 AM
Sirgo Mark ADirectorNov 18, 2021 Buy$1.0620,00021,2001,192,595Nov 22, 2021, 07:30 AM
Temperato JohnChief Executive OfficerNov 18, 2021 Buy$1.0550,00052,5001,152,522Nov 19, 2021, 07:31 AM
Sitar Edward JChief Financial OfficerSep 14, 2021 Buy$1.2215,00018,300194,338Sep 15, 2021, 08:12 AM
Sirgo Mark ADirectorSep 07, 2021 Buy$1.3673,52999,9991,172,595Sep 08, 2021, 08:15 AM
Constantino Michael T.DirectorAug 24, 2021 Buy$1.1418,00020,52052,108Aug 26, 2021, 08:18 AM
Sirgo Mark ADirectorAug 20, 2021 Buy$1.1025,00027,5001,099,066Aug 23, 2021, 08:15 AM
Temperato JohnChief Executive OfficerAug 18, 2021 Buy$1.0525,00026,2501,102,522Aug 19, 2021, 08:16 AM
OrbiMed Israel GP Ltd.10% OwnerJun 24, 2021 Sale$1.38319,255440,57224,555,850Jun 25, 2021, 07:08 PM
OrbiMed Israel GP Ltd.10% OwnerJun 23, 2021 Sale$1.36841,6501,144,64424,875,105Jun 25, 2021, 07:08 PM
OrbiMed Israel GP Ltd.10% OwnerJun 25, 2021 Sale$1.2115,989,87619,347,7518,565,974Jun 25, 2021, 07:08 PM
Temperato JohnChief Executive OfficerDec 15, 2020 Buy$0.65153,846100,000977,522Dec 17, 2020, 04:17 PM
Sirgo Mark ADirectorDec 15, 2020 Buy$0.65230,769150,000774,066Dec 17, 2020, 04:17 PM
Sitar Edward JChief Financial OfficerDec 15, 2020 Buy$0.6561,53840,000129,338Dec 17, 2020, 04:17 PM
Sirgo Mark ADirectorSep 11, 2020 Buy$0.6877,00052,360538,784Sep 14, 2020, 08:06 AM
Sirgo Mark ADirectorSep 10, 2020 Buy$0.6050,00030,000461,784Sep 14, 2020, 08:06 AM
Sirgo Mark ADirectorSep 11, 2020 Buy$0.6521,48514,00421,485Sep 14, 2020, 08:06 AM
Temperato JohnChief Executive OfficerAug 21, 2020 Buy$0.6970,00048,300615,496Aug 24, 2020, 07:01 AM
Constantino Michael T.DirectorAug 20, 2020 Buy$0.7534,10825,58134,108Aug 21, 2020, 04:20 PM
Sirgo Mark ADirectorAug 17, 2020 Buy$0.56100,00056,000411,784Aug 18, 2020, 05:19 PM
Temperato JohnChief Executive OfficerAug 17, 2020 Buy$0.5735,00019,831545,496Aug 17, 2020, 04:18 PM
Sirgo Mark ADirectorJun 15, 2020 Buy$0.6017,94310,72157,384Jun 16, 2020, 04:05 PM
Temperato JohnChief Executive OfficerJun 15, 2020 Buy$0.6010,0005,97149,441Jun 15, 2020, 04:56 PM
Laumas SandeepCEO, Executive ChairmanJun 28, 2019 Buy$1.154,0004,60018,000Jul 01, 2019, 05:00 PM
Laumas SandeepCEO, Executive ChairmanJun 13, 2019 Buy$1.221,0001,21614,000Jun 17, 2019, 08:03 PM
Madan Jay P.PresidentMay 30, 2019 Buy$1.325,0006,60084,131Jun 03, 2019, 08:00 AM
Proujansky RoyDirectorMay 24, 2019 Buy$1.281,0001,2802,400May 28, 2019, 04:30 PM
Laumas SandeepCEO, Executive ChairmanMay 22, 2019 Buy$1.385,0006,90013,000May 23, 2019, 08:44 AM
Proujansky RoyDirectorNov 30, 2018 Buy$2.631,4003,6821,400Dec 03, 2018, 07:18 PM
Laumas SandeepExecutive ChairmanNov 30, 2018 Buy$2.633,0007,8908,000Dec 03, 2018, 07:16 PM
Prior Christopher P.Chief Executive OfficerNov 29, 2018 Buy$2.755,00013,7507,009Nov 29, 2018, 08:00 PM
Laumas SandeepExecutive ChairmanNov 29, 2018 Buy$2.563,0007,6705,000Nov 29, 2018, 06:13 PM
Prior Christopher P.Chief Executive OfficerSep 14, 2018 Buy$5.822001,1642,009Sep 14, 2018, 06:58 PM
Prior Christopher P.Chief Executive OfficerSep 12, 2018 Buy$6.135003,0651,809Sep 13, 2018, 06:00 PM
Laumas SandeepExecutive ChairmanSep 07, 2018 Buy$6.105003,0502,000Sep 10, 2018, 05:49 PM
Laumas SandeepExecutive ChairmanAug 30, 2018 Buy$5.245002,620750Aug 30, 2018, 08:41 PM
Prior Christopher P.Chief Executive OfficerAug 30, 2018 Buy$5.203091,6071,309Aug 30, 2018, 08:39 PM
Laumas SandeepExecutive ChairmanAug 28, 2018 Buy$4.902501,225250Aug 30, 2018, 08:38 PM
Prior Christopher P.Chief Executive OfficerAug 28, 2018 Buy$4.931,0004,9301,000Aug 28, 2018, 06:19 PM
Laumas SandeepExecutive ChairmanAug 28, 2018 Buy$5.017503,7591,000Aug 28, 2018, 06:17 PM
Almenoff June SherieCOO and Chief Medical OfficerAug 24, 2018 Buy$4.911,0004,9061,400Aug 28, 2018, 04:33 PM
Almenoff June SherieCOO and Chief Medical OfficerAug 27, 2018 Buy$4.954001,979900Aug 28, 2018, 04:33 PM
CLARKE DAVID HFormer CEO and DirectorJan 26, 2018 Buy$0.35300,000105,0001,718,450Mar 13, 2018, 10:00 PM
CLARKE DAVID HFormer CEO and DirectorNov 29, 2017 Buy$0.45366,159164,7721,375,704Mar 13, 2018, 10:00 PM
CLARKE DAVID HFormer CEO and DirectorJun 23, 2017 Buy$0.58172,414100,000862,457Mar 13, 2018, 10:00 PM
CLARKE DAVID HFormer CEO and DirectorMar 16, 2017 Buy$1.5070,000105,000690,043Mar 13, 2018, 10:00 PM
CLARKE DAVID HFormer CEO and DirectorJul 13, 2016 Buy$4.5015,00067,500445,043Mar 13, 2018, 10:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Sensenig BethanyChief Financial Officer04/21/202311,011
Sirgo Mark ADirector07/01/202242,962
Temperato JohnChief Executive Officer07/06/202228,462
Sirgo Mark ADirector07/01/202242,962
Constantino Michael T.Director05/23/20227,608
Temperato JohnChief Executive Officer05/18/202222,285
Sirgo Mark ADirector05/18/202250,000
Constantino Michael T.Director08/20/202020,001
Sirgo Mark ADirector03/03/202250,003
Temperato JohnChief Executive Officer03/03/202255,590
Sirgo Mark ADirector12/02/202144,500
Sirgo Mark ADirector11/18/202121,200
Temperato JohnChief Executive Officer11/18/202152,500
Sitar Edward JChief Financial Officer09/14/202118,300
Sirgo Mark ADirector09/07/202199,999
Constantino Michael T.Director08/24/202120,520
Sirgo Mark ADirector08/20/202127,500
Temperato JohnChief Executive Officer08/18/202126,250
OrbiMed Israel GP Ltd.10% Owner06/24/2021440,572
OrbiMed Israel GP Ltd.10% Owner06/23/20211,144,644
OrbiMed Israel GP Ltd.10% Owner06/25/202119,347,751
Temperato JohnChief Executive Officer12/15/2020100,000
Sirgo Mark ADirector12/15/2020150,000
Sitar Edward JChief Financial Officer12/15/202040,000
Sirgo Mark ADirector09/11/202052,360
Sirgo Mark ADirector09/10/202030,000
Sirgo Mark ADirector09/11/202014,004
Temperato JohnChief Executive Officer08/21/202048,300
Constantino Michael T.Director08/20/202025,581
Sirgo Mark ADirector08/17/202056,000
Temperato JohnChief Executive Officer08/17/202019,831
Sirgo Mark ADirector06/15/202010,721
Temperato JohnChief Executive Officer06/15/20205,971
Laumas SandeepCEO, Executive Chairman06/28/20194,600
Laumas SandeepCEO, Executive Chairman06/13/20191,216
Madan Jay P.President05/30/20196,600
Proujansky RoyDirector05/24/20191,280
Laumas SandeepCEO, Executive Chairman05/22/20196,900
Proujansky RoyDirector11/30/20183,682
Laumas SandeepExecutive Chairman11/30/20187,890
Prior Christopher P.Chief Executive Officer11/29/201813,750
Laumas SandeepExecutive Chairman11/29/20187,670
Prior Christopher P.Chief Executive Officer09/14/20181,164
Prior Christopher P.Chief Executive Officer09/12/20183,065
Laumas SandeepExecutive Chairman09/07/20183,050
Laumas SandeepExecutive Chairman08/30/20182,620
Prior Christopher P.Chief Executive Officer08/30/20181,607
Laumas SandeepExecutive Chairman08/28/20181,225
Prior Christopher P.Chief Executive Officer08/28/20184,930
Laumas SandeepExecutive Chairman08/28/20183,759
Almenoff June SherieCOO and Chief Medical Officer08/24/20184,906
Almenoff June SherieCOO and Chief Medical Officer08/27/20181,979
CLARKE DAVID HFormer CEO and Director01/26/2018105,000
CLARKE DAVID HFormer CEO and Director11/29/2017164,772
CLARKE DAVID HFormer CEO and Director06/23/2017100,000
CLARKE DAVID HFormer CEO and Director03/16/2017105,000
CLARKE DAVID HFormer CEO and Director07/13/201667,500
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR 9 METERS BIOPHARMA INC
STOCK BUYBACKS FOR 9 METERS BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2022
09/30/2022
0.38%
1Q
12/31/2022
06/30/2022
0.42%
2Q
12/31/2022
03/31/2022
0.72%
3Q
12/31/2022
12/31/2021
1.26%
4Q
12/31/2022
09/30/2021
2.28%
5Q
12/31/2022
06/30/2021
4.22%
6Q
12/31/2022
03/31/2021
23.10%
7Q
Load More

Period of Report: 12/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2022
0.38%
1Q
06/30/2022
0.42%
2Q
03/31/2022
0.72%
3Q
12/31/2021
1.26%
4Q
09/30/2021
2.28%
5Q
06/30/2021
4.22%
6Q
03/31/2021
23.10%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR 9 METERS BIOPHARMA INC
LOADING...